SCHEMBL874811

SCHEMBL874811

COC(=O)C(CCO)SCCc1ccc(-c2ccc(Cl)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 4/20 0.39
PPARG P37231 3/20 0.39
MCHR1 Q99705 2/20 0.39
GAA P10253 3/20 0.38
ALDH1A1 P00352 3/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
PLAAT3 P53816 1/20 0.37
PLAAT5 Q96KN8 1/20 0.37
PLAAT2 Q9NWW9 1/20 0.37
PLAAT4 Q9UL19 1/20 0.37
P2RX3 P56373 1/20 0.36
MMP2 P08253 1/20 0.36
MMP3 P08254 1/20 0.36
CNR1 P21554 1/20 0.36
CYP4F2 P78329 1/20 0.35
CYP4A11 Q02928 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL874672 0.83 MCHR1 (0.38) PPARAPPARGMCHR1L3MBTL1PLAAT3
SCHEMBL878614 0.74 TSHR (0.46) ALDH1A1LMNAMAPTHPGDHTT
SCHEMBL875347 0.71 MEN1 (0.36) PPARAPPARGMCHR1GAAALDH1A1
SCHEMBL3467613 0.70 PPARA (0.50) PPARAPPARGGAALMNAHTT
SCHEMBL16798285 0.70 KMT2A (0.46) PPARAPPARGALDH1A1MMP2SLC6A3
SCHEMBL875071 0.69 PPARA (0.37) PPARAPPARGMCHR1GAAALDH1A1
SCHEMBL17590264 0.69 L3MBTL1 (0.48) PPARAPPARGGAAALDH1A1LMNA
SCHEMBL3715941 0.69 DPP4 (0.47) PPARAPPARGGAAALDH1A1LMNA
SCHEMBL16314618 0.69 L3MBTL1 (0.48) PPARAPPARGGAAALDH1A1LMNA
SCHEMBL3715937 0.69 DPP4 (0.47) PPARAPPARGGAAALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140148459-A1 MATRIX METALLOPROTEINASE INHIBITORS RANBAXY LABORATORIES LIMITED (IN) 2014-05-29 US disclosed
EP-2619185-A1 MATRIX METALLOPROTEINASE INHIBITORS Ranbaxy Laboratories Limited (IN) 2013-07-31 EP disclosed
WO-2012038942-A1 MATRIX METALLOPROTEINASE INHIBITORS RANBAXY LABORATORIES LIMITED (IN) 2012-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140148459-A1 MATRIX METALLOPROTEINASE INHIBITORS MMP9, MMP12, MMP10 PPARA 1792/4885PPARG 891/4885MCHR1 4214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.